Last updated 51 days ago

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

200 patients around the world
Available in Argentina, United States
Mirum Pharmaceuticals, Inc.
1Research sites
200Patients around the world
This study is for people with
Cholangitis
Sclerosing cholangitis
Requirements for the patient
From 12 Years
All Gender
Medical requirements
Sites
Glenny Corp S.A.
Recruiting
Ruiz Huidobro 4693, CABA, Buenos Aires
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy